Skip to main content
Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
1.230
-0.100 (-7.52%)
At close: Nov 13, 2026, 4:00 PM EST
1.250
+0.020 (1.63%)
After-hours: Nov 13, 2026, 4:25 PM EST

Kiora Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1-16.02---
Revenue Growth
------
Gross Profit
-2.71-3.7111.12-4.03-3.45-5.35
Operating Income
-8.9-9.465.58-8.69-10.73-10.57
Net Income
-12.76-10.843.59-13.04-13.58-13.77
Earnings Per Share
-2.45-2.640.87-24.25-166.94-514.04
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
16.2917.0926.792.455.967.85
Total Debt
0.290.370.060.110.110.21
Net Cash (Debt)
1616.7226.732.355.867.65
Net Cash Growth
-15.66%-37.46%1038.72%-59.93%-23.37%1150.70%
Net Cash Per Share
3.074.016.484.3672.00285.39

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.79-9.968.56-9.56-10.43-10.68
Capital Expenditures
-0.11-0.11-0.01---0.06
Free Cash Flow
-7.9-10.078.55-9.56-10.43-10.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-271.42%-69.43%---
Operating Margin
-890.17%-34.84%---
Pretax Margin
-1324.72%-35.33%---
Profit Margin
-1276.30%-22.44%---
FCF Margin
-789.82%-53.39%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--3.91---
P/FCF Ratio
--1.65---
PS Ratio
7.83-0.88---